ZYBERNO
Stock Report
Updated Sep 1, 2026

Regenerative Medical Technology Group Inc. (RMTG)

Consumer Discretionary • OTC

$0.10

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
Regenerative Medical Technology Group Inc. (RMTG) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.5%)
Return on Capital (Capital Efficiency):CRITICAL (0.7%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Regenerative Medical Technology Group Inc. (RMTG) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, RMTG generated -$985.05K in Owner Earnings.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.10
Market Cap:$1.36M

Valuation Multiples (2)

P/S Ratio:0.14x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$689.34K
Ev Ebitda Ratio:1.70x

Price Action & Momentum (2)

B. Profitability Assessment

Return Metrics (2)

Margin Analysis (3)

Operating Margin Ttm:0.5%
Net Margin Ttm:-101.2%
Ebitda Margin:4.3%

TTM Performance (3)

Gross Margin Ttm:59.8%
Operating Margin Ttm:0.5%
Net Margin Ttm:-101.2%

Yield Metrics (2)

Earnings Yield:-$1.42K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-223.5%
Latest Earnings Filed:2026-08-19

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):63.3%

Cash Flow Growth (Linear) (1)

Operating Cash Flow Growth Rate (Linear):96.5%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.05x
Quick Ratio:0.04x
Cash Ratio:0.03x

Leverage Analysis (1)

Debt To Ebitda:1.60x

Coverage Ratios (2)

Interest Coverage Ratio:-0.09x
Times Interest Earned:-0.09

Capital Structure (4)

Working Capital:-40,328,418.00
Cash And Cash Equivalents:1,323,304.00
Long Term Debt:$492.43K
Net Debt:-$673.20K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $9.41M
Linear Growth: 63.3%
📊 Click to view full RMTG Revenue analysis & methodology →
Cost Of Revenue Ttm:$3.79M

Profitability Breakdown (2)

Gross profit TTM: $5.63M
Linear Growth: 65.6%
📊 Click to view full RMTG Gross Profit analysis & methodology →
$43.72K

Bottom Line Performance (3)

-$9.53M
Income Before Tax:$0.00
Ebitda Ttm:406,649.00

Operating Expenses (5)

Operating Expenses:5,581,990.00
R And D Expense:0.00
Sga Expense:1,761,991.00
Income Tax Expense:-$1.64M
Interest Expense:9,922,905.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:43.8%
Ebitda Margin:4.3%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$5.85M
Current Assets:$2.28M
Ppe Net:1,089,917.00
Goodwill:1,679,978.00
Intangible Assets:$12.69K

Liability Structure (4)

Total Liabilities:45,105,519.00
Current Liabilities:42,613,096.00
Long Term Debt:$492.43K
Short Term Debt:$157.68K

Equity & Capital (3)

Equity:-$39.26M
Retained Earnings:-$79.48M
Common Stock:100,000,000.00

Working Capital Items (3)

Accounts Receivable:110,244.00
Inventory:481,168.00
Accounts Payable:19,615,846.00

Special Items (2)

Contract Liabilities:431,936.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$661.50K
Linear Growth: 96.5%
-$1.52M

Investment Activities (1)

Investing Cash Flow:-$315.39K

Financing Activities (3)

Financing Cash Flow:$318.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$318.00K
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:362,925.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.75
-$0.75
Earnings Per Share Ttm:-$0.72

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.71
Operating Cash Flow Per Share:-$0.05

Book Value & Capital (2)

Book Value Per Share:-$2.97
Cash Per Share:0.10

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.90x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:85.40x
Days Sales Outstanding Ttm:4.27

Inventory Management (2)

Inventory Turnover Ttm:7.87x
Days Inventory Outstanding Ttm:46.35

Payables & Cash Cycle (2)

Days Payable Outstanding:1,889.69
Cash Conversion Cycle:-1,839.07
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$985.05K
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):63.3%

Cash Flow Growth Rates (1)

Operating Cash Flow Growth Rate (Linear):96.5%

Other Growth Rates (1)

Gross Profit Growth Rate (Linear):65.6%
C. Company Profile & Context

Corporate Information (6)

Symbol:RMTG
Company Name:Regenerative Medical Technology Group Inc.
Sector:Consumer Discretionary
Industry:Retail-Retail Stores, NEC
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:13.22M
Shares Outstanding Basic:13.22M
Shares Outstanding Diluted:13.22M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 22:57:55 UTC
Data Timestamp:2026-08-22T18:56:59.142347
Scroll to Top